US20050241736A1 - Surface treatment of co-cr based alloys using plasma carburization - Google Patents

Surface treatment of co-cr based alloys using plasma carburization Download PDF

Info

Publication number
US20050241736A1
US20050241736A1 US10/513,129 US51312905A US2005241736A1 US 20050241736 A1 US20050241736 A1 US 20050241736A1 US 51312905 A US51312905 A US 51312905A US 2005241736 A1 US2005241736 A1 US 2005241736A1
Authority
US
United States
Prior art keywords
article
carbon
range
plasma
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/513,129
Inventor
Thomas Bell
Hanshan Dong
Chenxi Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADSURFENG Ltd
Original Assignee
ADSURFENG Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADSURFENG Ltd filed Critical ADSURFENG Ltd
Assigned to AD.SURF.ENG LTD reassignment AD.SURF.ENG LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BELL, THOMAS, DONG, HANSHAN, LI, CHENXI
Publication of US20050241736A1 publication Critical patent/US20050241736A1/en
Priority to US13/946,569 priority Critical patent/US20130304219A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/06Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases
    • C23C8/08Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases only one element being applied
    • C23C8/20Carburising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/045Cobalt or cobalt alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/303Carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C19/00Alloys based on nickel or cobalt
    • C22C19/07Alloys based on nickel or cobalt based on cobalt
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/06Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases
    • C23C8/36Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases using ionised gases, e.g. ionitriding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30682Means for preventing migration of particles released by the joint, e.g. wear debris or cement particles
    • A61F2002/30685Means for reducing or preventing the generation of wear particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30922Hardened surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30934Special articulating surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00029Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium

Definitions

  • the present invention relates to a process for producing a superior wear-resistant surface on cobalt-chromium (Co—Cr) based alloy articles. Particularly but not exclusively, it relates to a surface hardening process applicable to cobalt-chromium (Co—Cr) based metal-on-metal orthopaedic implant devices (prostheses), wherein surface hardness and wear resistant properties of the prostheses are enhanced without loss of corrosion resistance.
  • Cobalt-chromium based alloys have typically been used for orthopaedic applications because of their strength, resistance to wear and corrosion and biocompatibility.
  • the cobalt-chromium alloy produces wear debris from the counterface surfaces in relative motion. This raises a major concern over the carcinogenic effect of such Co—Cr wear debris and the release of such metal ions as Co and Cr. Therefore, the surface of the Co—Cr alloys must be hardened in order to minimise wear, thus leading to long-life Co—Cr orthopaedic prostheses.
  • Several methods for improving wear resistance of Co—Cr based alloys and such articles made from these alloys have been attempted.
  • Co—Cr alloys This oxide scale frequently cause a poor adhesion between a coating and the Co—Cr alloy surface.
  • Surface treatment of Co—Cr alloys usually has to overcome this major problem, and consequently, such coating techniques as PVD coating, electroplating, and electrolysis plating have limitations for Co—Cr alloys, as compared with coating and plating for most ferrous alloys.
  • the thickness of the modified surface layer (normally in the range of 0.01 to 0.2 ⁇ m) is far less than the average annual linear wear rate of Co—Cr—Mo prostheses.
  • known surface-hardening methods include gas nitriding or plasma nitriding.
  • a nitriding process is disclosed in detail in U.S. Pat. No. 5,912,323 issued on May 3, 1994 entitled “METHOD OF SURFACE HARDENING COBALT-CHROMIUM ALLOYS FOR ORTHOPAEDIC IMPLANT DEVICES”, which disclosure is hereby incorporated by reference.
  • a treatment duration as long as 48 hours needs to be used.
  • the thickness of the effectively hardened layer is very small as evidenced by the statement that “the peak nitrogen concentration occurs at a depth between 10 and 100 nm”. This is largely due to the strong affinity between nitrogen and chromium.
  • the present invention provides an improved surface hardening process which is relatively cost-effective and which is capable of producing, at a relatively low temperature, combined improvement in wear and corrosion resistance of Co—Cr based alloy joint prostheses (such as hip and knee joints) and producing highly wear-resistant Co—Cr based alloy engineering components (such as valves and tools) without undue loss in corrosion resistance.
  • a method of modifying a surface characteristic of a cobalt-chromium based alloy article comprising plasma treating the article at a temperature in the range of from 300 to 700° C. and at a pressure of from 100 to 1500 Pa for 1 to 50 hours in an atmosphere comprising at least one carbon-containing gas, whereby to introduce carbon into a surface region of said article.
  • the surface characteristic to be modified by the method of the present invention may be any one or more of hardness, wear resistance, corrosion resistance and fatigue strength.
  • said article is a medical implant, such as a joint or knee prosthesis, in which case said plasma treating is preferably carried out at a temperature in the range of from 350 to 550° C., and more preferably 400 to 500° C. At these temperatures, the method generally increases wear resistance and corrosion resistance.
  • said article may be an engineering component, such as a knife, valve, blades or shaft, in which case said plasma treating is preferably carried out at a temperature in the range of from 450 to 700° C., more preferably 600 to 650° C. At these temperatures, the method generally increase wear resistance, but not necessarily corrosion resistance.
  • said treatment pressure is in the range of from 400 to 600 Pa and is more preferably about 500 Pa.
  • the duration of said treatment is in the range of from 2 to 50 hours and more preferably 5 to 30 hours.
  • the or each carbon-containing gas is selected from a hydrocarbon (eg. methane), carbon dioxide and carbon monoxide.
  • a hydrocarbon eg. methane
  • carbon dioxide e.g., carbon dioxide
  • carbon monoxide e.g., carbon dioxide
  • the plasma treatment is carried out in the presence of at least one unreactive gas, for example selected from hydrogen, helium, argon or other noble gas.
  • unreactive relates to a gas which does not become incorporated into the article to any significant extent.
  • the plasma treatment is carried out in the presence of at least one reactive gas, such as a nitrogen containing gas (eg. N 2 or ammonia).
  • a nitrogen containing gas eg. N 2 or ammonia
  • reactive relates to a gas which (or a part of which) does become incorporated into the article to a certain extent.
  • the plasma treating step is preferably effected at a temperature of from 300 to 500° C.
  • Particularly preferred gas mixtures are hydrogen and methane, and hydrogen, argon and methane.
  • the or each carbon-containing gas constitutes from 0.5 to 20% by volume of the total atmosphere.
  • said reactive gas (when present) constitutes from 0.5 to 10% by volume of the total atmosphere.
  • said plasma treatment is effected in the absence of oxygen.
  • the method may include an article cleaning step prior to the plasma treatment step to remove any oxide scale.
  • said cleaning is effected by sputter cleaning (i.e. bombardment of the article surface with positive ions).
  • Said cleaning step may be effected at or below the plasma treatment temperature in an atmosphere of one or more of gases selected from hydrogen, helium, argon or other noble gas.
  • the rate of cooling may be anything from 0.1° C./min up to 1000° C./min. Cooling may be achieved by slow cooling in the plasma treating atmosphere or by fast cooling by quenching in a liquid. In order to prevent dimension distortion and oxidation, slow cooling in the plasma treating atmosphere is preferred.
  • a passivation and/or polishing step may be desirable after completion of the plasma treatment.
  • the present invention also resides in a surface-hardened cobalt-chromium based article producible by the method of the present invention, said article characterised by having:
  • said surface region has a thickness in the range of from 3 to 50 ⁇ m.
  • Co—Cr based alloy is not particularly limited, and for example, any other alloying ingredients such as molybdenum, nickel, tungsten and titanium may be included in the alloy composition.
  • Carbon may also be included, preferably in the range of from 0.04 to 1.6 wt %, more preferably in the range of 0.04 to 0.4 wt % in the case of a medical implant, and 0.4 to 1.6 wt % in the case of an engineering component.
  • Co—Cr based alloys which are useful for joint prostheses are ASTM F75 (ISO5832/4), ASTM F799 (ISO5832/12), ASTM F90 (ISO5832/5) and ASTM F562 (ISO5832/6) or their equivalents with different trade names.
  • Articles formed of these alloys which can be surface treated at a relatively low temperature (300-500° C.) in accordance with the present invention include conventional hip and knee joint prostheses, metal-on-metal advanced bone conservation prostheses, dental implants and other implant devices.
  • Co—Cr based alloys which are useful for wear and/or corrosion resistant engineering components are Stellite 6B, Stellite 6K, MP35N and Ultimet.
  • Wear-resistant engineering components made of these Co—Cr based alloys which can be surface treated at a relatively high temperature (600-700° C.) in accordance with the present invention include knifes and blades for chemical and food processing industrials, valves and pumps in the chemical and power industrials, bushings and steel mill equipment.
  • the Co—Cr based alloys which are useful for hardfacing deposits are the Stellite family (more than 20 alloys) and ERCoCr alloys (ERCoCr-A, -B, -C or -E).
  • Articles deposited with these hardfacing alloys which are preferably surface treated at a relatively high temperature (300-700° C.) in accordance with the present invention include valves, dies, punches, moulds, turbine blades and knifes.
  • FIG. 1 is a schematic view of a dc plasma unit in which the treatment described in the preferred embodiments below was effected
  • FIG. 2 is a micrograph of the cross-sectional microstructure of a Co—Cr—Mo test piece treated in accordance with the present invention
  • FIG. 3 shows XRD patterns for untreated test pieces and test pieces surface hardened in accordance with the present invention
  • FIGS. 4-6 are graphs showing the properties of untreated test pieces and test pieces surface hardened in accordance with the present invention.
  • Co—Cr based alloys which are susceptible to the process of the present invention are summarised in Table 1.
  • the Co—Cr based alloys of which the article is formed may be in the wrought, cast, hardfacing deposit or PM/HIP form before the article is subjected to the process to the present invention.
  • the surface-treatment-process can be applied as a final procedure without causing deterioration of the properties of the substrate or dimensional distortion of the article.
  • Articles for which the process of the present invention is suitable include articles as ferrules, valves, gears and shafts. There is no particular limit in the size of articles that can be treated using the process of the present invention.
  • the apparatus comprises a sealable vessel 10 , a vacuum system 12 with a rotary pump (not shown), a dc power supply and control unit 14 , a gas supply system 16 , a temperature measurement and control system 18 including a thermocouple 24 , and a work table 20 for supporting articles 22 to be treated.
  • the articles 22 to be treated were Co—Cr based alloy discs 25 mm in diameter and 8 mm in thickness.
  • the discs were placed on the table 20 inside the vessel 10 .
  • the table 20 was connected as a cathode to the power supply and control unit 14 , and the wall of the vessel 10 was connected to the dc source as the anode.
  • the temperature of the discs 22 was measured by the thermocouple 24 inserted into a hole of 3 mm diameter drilled in one of the discs 22 or a dummy sample.
  • the rotary pump was used to remove the residual air (oxygen) and thus reduce the pressure in the vessel.
  • an external heater attached to the vessel may be employed, or a combination of external heating and electrical glow discharge heating may be employed.
  • Direct current (dc) discharge, pulsed dc discharge or alternating current (ac) discharge may be used.
  • the methane is ionised, activated and dissociated to produce carbon ions and activated carbon atoms and neutral molecules, which then diffuse into the surface of the disc forming a carbon diffusion layer.
  • the carbon atoms mainly reside in the cobalt lattices, forming a supersaturated solid solution with a possible nanocrystalline structure due to the relatively low temperatures employed in the treatment.
  • the resultant layer has a high hardness, good fatigue strength and excellent wear and corrosion resistance (see below).
  • the carbon atoms When the plasma treatment is carried out at a relatively high temperature ranging from 600 to 700° C., the carbon atoms partially reside in the cobalt lattices forming a supersaturated solid solution and partially combined with carbon forming chromium carbides.
  • the resultant layer has a high hardness, fatigue strength and excellent wear resistance.
  • the glow discharge was turned off and the articles 22 were allowed to cool in the vessel 10 in the treatment atmosphere down to room temperature before they were removed from the vessel.
  • the articles 22 were then subjected to X-ray diffraction analysis for phase identification, glow discharge spectrometry (GDS) analysis for chemical composition determination, surface hardness measurements, metallography analysis of the cross section, electrochemical corrosion tests and wear tests.
  • GDS glow discharge spectrometry
  • FIG. 2 A typical micrograph showing the cross-section of the carburised sample is given in FIG. 2 .
  • the sample was electrolytically etched in a 10% H 2 SO 4 water solution. It can be seen that the carburised specimen is characterised by an “un-etched layer” on the surface followed by a carbon diffusion layer (“case”) beneath and the heavily etched substrate (“core”). The un-etched layer is dense, no details can be revealed even under high resolution FEG-SEM.
  • the thickness of the total carburised case depth increases with increasing carburising temperature. In conjunction with the chemical composition analysis, the case depth was determined to be 3.1, 9.3 and 20.2 ⁇ m respectively for the A-sample treated at 400° C., 500° C. and 600° C. for 10 hours.
  • FIG. 3 shows the XRD patterns for the untreated and carburised Co-27.6Cr-5.5Mo-0.06C alloy (Sample A).
  • the untreated alloy consists of a mixture of f.c.c. structured ⁇ -Co and h.c.p. structured ⁇ -Co. It can be deduced from the height of the XRD peaks that the untreated alloy contains mainly ⁇ with a small amount of ⁇ . Plasma carburising has changed the phase constituent in the alloy surface. As shown in FIG. 3 , only two main diffraction peaks at lower angles and some minor peaks at higher angles are detected.
  • FIG. 4 shows micro hardness measured on the sample A surface with various load. It can be seen that the hardness on the untreated surface (A000) is fairly stable under a testing load of above 0.05 kg, with an average value of HV 486. After carburising, the surface hardness of the Co—Cr—Mo alloy was increased under all testing loads. Under indentation loads below 0.1 kg, surface hardness values of more than 1100 HV were obtained for the 500° C. and 600° C. treated samples (A500 and A600 respectively). The surface hardness values for the 400° C.
  • treated sample (A400) were not as high as those for the 500° C. and 600° C. treated samples, but they are still much higher than those for the untreated alloy.
  • Such a diffusion type of hardness distribution is essential in ensuring optimum performance of surface treated system, since a sudden structural, compositional, and property change at the layer/core interface may lead to catastrophic interfacial failure of the layer during service. It was also found that the edges of the Vickers indentation impressions on the carburised samples were sharp and clear.
  • Plasma carburised and untreated test pieces were subjected to pin (WC ball)-on-disc wear tests sliding against 8 mm WC balls at a speed of 0.03 m/s with a initial maximum Hertzian contact stress of 1500 MP. Wear rate, in terms of volume loss per meter sliding distance per Newton load (mm 3 m ⁇ 1 N ⁇ 1 ), was calculated and is shown in FIG. 5 . As can be seen from FIG. 5 , the wear rate of all the carburised test pieces was dramatically reduced by more than one order of magnitude as compared with the untreated test pieces.
  • Electrochemical potentiondynamic sweep corrosion tests were conducted at room temperature in a flat cell with Ringer's solution which contained 9 g/l sodium chloride, 0.42 g/l potassium chloride, 0.48 g/l calcium chloride and 0.2 g/l sodium bicarbonate in distilled water.
  • the polarisation curves are shown in FIG. 6 .
  • the corrosion potentials of all plasma carburised test pieces were moved to more passive values, indicating improved corrosion resistance.
  • the current densities of both the untreated and the A400 and A500 test pieces are practically the same.
  • the A600 test piece showed a higher current density scan potential was over ⁇ 0.2V.
  • an advanced active screen plasma technology can be used to treat articles made of Co—Cr based alloys with improved surface quality.
  • the articles to be plasma treated are placed inside a metal screen which is connected to the cathodic potential.
  • the worktable and the articles to be treated are placed in a floating potential or subject to a relatively lower bias voltage (e.g. ⁇ 100 ⁇ 200V).
  • a casting material material D in Table 3

Abstract

The present invention relates to a method of modifying a surface characteristic (eg. wear resistance and/or corrosion resistance) of a cobalt-chromium based alloy article. The method comprises plasma treating the article at a temperature in the range of from 300 to 700° C. and at a pressure of from 100 to 1500 Pa for 1 to 50 hours in an atmosphere comprising at least one carbon-containing gas, whereby to introduce carbon into a surface region of said article. The present invention also resides in a surface-hardened cobalt-chromium based article producible by the method of the invention. The article is characterised by having a surface region comprising a supersaturated solid solution of carbon in cobalt or a surface region comprising a supersaturated solid solution of carbon in cobalt and chromium carbides. Surface hardened articles producible by the method of the invention include medical implants and engineering components.

Description

  • The present invention relates to a process for producing a superior wear-resistant surface on cobalt-chromium (Co—Cr) based alloy articles. Particularly but not exclusively, it relates to a surface hardening process applicable to cobalt-chromium (Co—Cr) based metal-on-metal orthopaedic implant devices (prostheses), wherein surface hardness and wear resistant properties of the prostheses are enhanced without loss of corrosion resistance.
  • Cobalt-chromium based alloys have typically been used for orthopaedic applications because of their strength, resistance to wear and corrosion and biocompatibility. However, under conditions of sliding wear or articulation of the Co—Cr alloy against other bearing surfaces (particularly, ceramics or Co—Cr alloy counterfaces), the cobalt-chromium alloy produces wear debris from the counterface surfaces in relative motion. This raises a major concern over the carcinogenic effect of such Co—Cr wear debris and the release of such metal ions as Co and Cr. Therefore, the surface of the Co—Cr alloys must be hardened in order to minimise wear, thus leading to long-life Co—Cr orthopaedic prostheses. Several methods for improving wear resistance of Co—Cr based alloys and such articles made from these alloys have been attempted.
  • One approach to enhancing the wear performance of metallic femoral components (hip and knee prostheses) is to coat their surfaces with such ceramic coatings as TiN (J. A. Davidson, Ceramics in substitutive and reconstructive surgery (P. Vincenzini ed), Elsevier, Amsterdam, 1991 pp 157-166) and more recently diamond-like carbon (DLC) coating (M. Allen, J. Biomed. Mater. Res., 58(2001), pp 319-328). Potential drawbacks to this approach are concerns over spallation of coatings (M. T. Raimondi and R. Pietrabissa, Biomaterials, 21(2000), pp 907-913) due to the non-metallurgical bonding and galvanic corrosion (caused by the large galvanic potential difference and pinholes in coatings) (R. S. Lillard et. al., Surface Engineering 15 (1999), pp 221-224). Although a TiN coating has been explored for use as a bearing surface against UHMWPE since the late 1980's, laboratory testing and clinical results have been limited. Indeed, it was reported in 1998 that 5,000 hip operations might have to be repeated in the UK, the problem being attributed to the TiN-coated surface (R. Ellis et. al., The Times, 19 Feb. 1998, p 1.). Although simple configuration laboratory tests indicated that the DLC coatings had exceptional friction and wear characteristics, tests on hip simulators produced early failures of the coatings (A. H. S. Jones and D. Teer ‘Friction and wear testing of DLC type coatings on total hip replacement prostheses’ Seminar on The Friction Lubrication and Wear of Artificial Joints—Tribology Meets Medical, Institute of Mechanical Engineers, 30 Nov. 2000, Leeds). Clearly there is cause for concern in using coatings for metallic femoral components. The problem is mainly due to the formation of an oxide scale (Cr2O3) on the alloy surface due to the strong affinity of chromium, which is a major alloying element of Cr—Co alloys, with oxygen in air. This oxide scale frequently cause a poor adhesion between a coating and the Co—Cr alloy surface. Surface treatment of Co—Cr alloys usually has to overcome this major problem, and consequently, such coating techniques as PVD coating, electroplating, and electrolysis plating have limitations for Co—Cr alloys, as compared with coating and plating for most ferrous alloys.
  • Another approach to improving the wear performance of femoral components is to modify the metallic surface. In this respect, ion implantation with nitrogen has been employed since the mid 1980's to improve wear resistance of metallic bearing surfaces made of Ti-6Al-4V, 316L and Co—Cr—Mo (J. I. Onate, Surface and Coatings Technology, 142-144 (2001), pp 1056-1062). However, it should be noted that the effectiveness of ion implantation in enhancing wear resistance of Co—Cr—Mo alloys for metal-on-metal articulation is limited by the inherent line-of-sight nature of the ion beam and the very thin modified layer which is produced. It is difficult, if not impossible, to produce a homogeneous surface modified layer on 3-D complexly shaped prostheses using the line-of-sight ion beams. In addition, the thickness of the modified surface layer (normally in the range of 0.01 to 0.2 μm) is far less than the average annual linear wear rate of Co—Cr—Mo prostheses.
  • In addition to ion implantation with nitrogen, known surface-hardening methods include gas nitriding or plasma nitriding. A nitriding process is disclosed in detail in U.S. Pat. No. 5,912,323 issued on May 3, 1994 entitled “METHOD OF SURFACE HARDENING COBALT-CHROMIUM ALLOYS FOR ORTHOPAEDIC IMPLANT DEVICES”, which disclosure is hereby incorporated by reference. To produce a measurable hardened layer, a treatment duration as long as 48 hours needs to be used. The thickness of the effectively hardened layer is very small as evidenced by the statement that “the peak nitrogen concentration occurs at a depth between 10 and 100 nm”. This is largely due to the strong affinity between nitrogen and chromium. Indeed, it was found that after plasma nitriding at 550° C. for 8 h in a 75% N2-25% H2 gas mixture, only a compound layer of CrN was observed in the nitrided case of Stellite 6B, a Co-30Cr alloy without the formation of an appreciable diffusion zone (P. H. Howill, Ion nitriding stellite in T. Spaluins and W. L. Kovaes (eds): Proceedings of 2nd International Conference of Ion Nitriding/Carburising. ASM International 1990, 175-176).
  • It is an object of the present invention to provide an improved method of treatment of Co—Cr based alloy articles, which can enable the above-mentioned disadvantages to be obviated or mitigated.
  • In general, the present invention provides an improved surface hardening process which is relatively cost-effective and which is capable of producing, at a relatively low temperature, combined improvement in wear and corrosion resistance of Co—Cr based alloy joint prostheses (such as hip and knee joints) and producing highly wear-resistant Co—Cr based alloy engineering components (such as valves and tools) without undue loss in corrosion resistance.
  • According to the present invention, there is provided a method of modifying a surface characteristic of a cobalt-chromium based alloy article, comprising plasma treating the article at a temperature in the range of from 300 to 700° C. and at a pressure of from 100 to 1500 Pa for 1 to 50 hours in an atmosphere comprising at least one carbon-containing gas, whereby to introduce carbon into a surface region of said article.
  • The surface characteristic to be modified by the method of the present invention may be any one or more of hardness, wear resistance, corrosion resistance and fatigue strength.
  • Preferably, said article is a medical implant, such as a joint or knee prosthesis, in which case said plasma treating is preferably carried out at a temperature in the range of from 350 to 550° C., and more preferably 400 to 500° C. At these temperatures, the method generally increases wear resistance and corrosion resistance.
  • Alternatively, said article may be an engineering component, such as a knife, valve, blades or shaft, in which case said plasma treating is preferably carried out at a temperature in the range of from 450 to 700° C., more preferably 600 to 650° C. At these temperatures, the method generally increase wear resistance, but not necessarily corrosion resistance.
  • Preferably, said treatment pressure is in the range of from 400 to 600 Pa and is more preferably about 500 Pa.
  • Preferably, the duration of said treatment is in the range of from 2 to 50 hours and more preferably 5 to 30 hours.
  • Preferably, the or each carbon-containing gas is selected from a hydrocarbon (eg. methane), carbon dioxide and carbon monoxide.
  • Preferably, the plasma treatment is carried out in the presence of at least one unreactive gas, for example selected from hydrogen, helium, argon or other noble gas. As used herein “unreactive” relates to a gas which does not become incorporated into the article to any significant extent.
  • Preferably, the plasma treatment is carried out in the presence of at least one reactive gas, such as a nitrogen containing gas (eg. N2 or ammonia). As used herein “reactive” relates to a gas which (or a part of which) does become incorporated into the article to a certain extent. Where a nitrogen-containing gas is used, the plasma treating step is preferably effected at a temperature of from 300 to 500° C.
  • Particularly preferred gas mixtures are hydrogen and methane, and hydrogen, argon and methane.
  • Preferably, the or each carbon-containing gas constitutes from 0.5 to 20% by volume of the total atmosphere. Preferably, said reactive gas (when present) constitutes from 0.5 to 10% by volume of the total atmosphere.
  • Preferably, said plasma treatment is effected in the absence of oxygen.
  • The method may include an article cleaning step prior to the plasma treatment step to remove any oxide scale. Preferably, said cleaning is effected by sputter cleaning (i.e. bombardment of the article surface with positive ions). Said cleaning step may be effected at or below the plasma treatment temperature in an atmosphere of one or more of gases selected from hydrogen, helium, argon or other noble gas.
  • It will be understood that after plasma treating, the article will be cooled. The rate of cooling may be anything from 0.1° C./min up to 1000° C./min. Cooling may be achieved by slow cooling in the plasma treating atmosphere or by fast cooling by quenching in a liquid. In order to prevent dimension distortion and oxidation, slow cooling in the plasma treating atmosphere is preferred.
  • Particularly for medical implants, a passivation and/or polishing step may be desirable after completion of the plasma treatment.
  • The present invention also resides in a surface-hardened cobalt-chromium based article producible by the method of the present invention, said article characterised by having:
      • (i) a surface region comprising a supersaturated solid solution of carbon in cobalt or,
      • (ii) a surface region comprising a supersaturated solid solution of carbon in cobalt and chromium carbides.
  • Preferably, said surface region has a thickness in the range of from 3 to 50 μm.
  • The nature of the Co—Cr based alloy is not particularly limited, and for example, any other alloying ingredients such as molybdenum, nickel, tungsten and titanium may be included in the alloy composition. Carbon may also be included, preferably in the range of from 0.04 to 1.6 wt %, more preferably in the range of 0.04 to 0.4 wt % in the case of a medical implant, and 0.4 to 1.6 wt % in the case of an engineering component.
  • Among the Co—Cr based alloys which are useful for joint prostheses are ASTM F75 (ISO5832/4), ASTM F799 (ISO5832/12), ASTM F90 (ISO5832/5) and ASTM F562 (ISO5832/6) or their equivalents with different trade names. Articles formed of these alloys which can be surface treated at a relatively low temperature (300-500° C.) in accordance with the present invention include conventional hip and knee joint prostheses, metal-on-metal advanced bone conservation prostheses, dental implants and other implant devices. Among the Co—Cr based alloys which are useful for wear and/or corrosion resistant engineering components are Stellite 6B, Stellite 6K, MP35N and Ultimet. Wear-resistant engineering components made of these Co—Cr based alloys which can be surface treated at a relatively high temperature (600-700° C.) in accordance with the present invention include knifes and blades for chemical and food processing industrials, valves and pumps in the chemical and power industrials, bushings and steel mill equipment. Among the Co—Cr based alloys which are useful for hardfacing deposits are the Stellite family (more than 20 alloys) and ERCoCr alloys (ERCoCr-A, -B, -C or -E). Articles deposited with these hardfacing alloys which are preferably surface treated at a relatively high temperature (300-700° C.) in accordance with the present invention include valves, dies, punches, moulds, turbine blades and knifes.
  • Embodiments of the present invention will now be described by way of example only, with reference to the accompanying drawings in which:
  • FIG. 1 is a schematic view of a dc plasma unit in which the treatment described in the preferred embodiments below was effected,
  • FIG. 2 is a micrograph of the cross-sectional microstructure of a Co—Cr—Mo test piece treated in accordance with the present invention,
  • FIG. 3 shows XRD patterns for untreated test pieces and test pieces surface hardened in accordance with the present invention, and
  • FIGS. 4-6 are graphs showing the properties of untreated test pieces and test pieces surface hardened in accordance with the present invention.
  • Typical examples of suitable Co—Cr based alloys which are susceptible to the process of the present invention are summarised in Table 1. The Co—Cr based alloys of which the article is formed may be in the wrought, cast, hardfacing deposit or PM/HIP form before the article is subjected to the process to the present invention.
    TABLE 1
    Examples of useful Co—Cr based alloys
    Alloy Cr Mo Ni W C Ti Co
    Wear-corrosion resistant biomedical alloys
    F75 27-30 5-7 <1 <0.35 bal
    (ISO5832/4)
    F799 26-30 5-7 <1 <0.35 bal
    (ISO5832/12)
    F90 19-21  9-11 14-16 <0.15 bal
    (ISO5832/5)
    F562 19-21  9-11 33-37 <0.15 <1 bal
    (ISO5832/6)
    Wear-resistant alloys
    Alloy 6B 28-32 <1.5 <2.5 3-5 0.8-1.2 bal
    Alloy 6K 28-32 <1.5 <2.5 3.5-5.5 1.5-1.7 bal
    Corrosion-resistant alloys
    MP35N 19-21  9-11 34-36 bal
    Ultimet 25-27 4-6  8-10 1-3 <0.06 bal
    Hardfacing alloys
    ERCoCr-A ˜28 ˜5 ˜1.2 bal
    ERCoCr-B ˜29 ˜8 ˜1.5 bal
    ERCoCr-C ˜31 ˜13 ˜2.5 bal
    ERCoCr-E ˜27 ˜6 ˜8 ˜0.2 bal
  • The surface-treatment-process can be applied as a final procedure without causing deterioration of the properties of the substrate or dimensional distortion of the article. Articles for which the process of the present invention is suitable include articles as ferrules, valves, gears and shafts. There is no particular limit in the size of articles that can be treated using the process of the present invention.
  • In order to demonstrate the advantages of the present invention, a series of Co—Cr based alloys (Table 2) were treated in accordance with the present invention.
  • In the Examples, surface treatment was carried out using a dc plasma nitriding apparatus shown in FIG. 1. The apparatus comprises a sealable vessel 10, a vacuum system 12 with a rotary pump (not shown), a dc power supply and control unit 14, a gas supply system 16, a temperature measurement and control system 18 including a thermocouple 24, and a work table 20 for supporting articles 22 to be treated.
    TABLE 2
    Alloy composition of the Examples
    Sample designation* Condition Composition (% by wt)
    A Wrought Co-27.6Cr-5.5Mo-0.06C
    B Wrought Co-37.4Cr-6.1Mo-0.19C
    C Cast (MMT) Co-29.2Cr-6.1Mo-0.21C
    D Cast (DEP) Co-27.2Cr-0.17C
    E Cast (DRILL) Co-29.6Cr-5.9Mo-0.05C
    F PM/HIP Co-28.2Cr-5.8Mo-0.04C

    *For each sample designation, a different sample was treated at 400, 500 and 600° C. (designated A400, A500, A600 etc.)
  • The articles 22 to be treated were Co—Cr based alloy discs 25 mm in diameter and 8 mm in thickness. The discs were placed on the table 20 inside the vessel 10. The table 20 was connected as a cathode to the power supply and control unit 14, and the wall of the vessel 10 was connected to the dc source as the anode. The temperature of the discs 22 was measured by the thermocouple 24 inserted into a hole of 3 mm diameter drilled in one of the discs 22 or a dummy sample. After the sealable vessel 10 was tightly closed, the rotary pump was used to remove the residual air (oxygen) and thus reduce the pressure in the vessel. When the reduction in pressure reached 10 Pa (0.1 mbar) or less, a glow discharge was introduced between the article 22 (cathode) and the vessel wall (anode) by applying a voltage of 400 volts to 900 volts between these two electrodes. A heating gas of hydrogen was at the same time introduced into the vessel 10. The pressure of the hydrogen gas in the vessel 10 was increased gradually as the temperature of the articles 22 increased. No external or auxiliary heating was employed, and the articles 22 were heated by the glow discharge only.
  • In other embodiments (not shown), an external heater attached to the vessel may be employed, or a combination of external heating and electrical glow discharge heating may be employed. Direct current (dc) discharge, pulsed dc discharge or alternating current (ac) discharge may be used.
  • After the articles 22 were heated to the prescribed temperature, a gas mixture of hydrogen (98.5%) and methane (1.5%) was introduced into the vessel 10 and the plasma treatment started. Treatment temperatures from 400° C. to 600° C. were employed for a treatment time of 10 hours. The working pressure in the treatment step was 500 Pa (5.0 mbar) for all the Examples.
  • During the plasma heat treatment, the methane is ionised, activated and dissociated to produce carbon ions and activated carbon atoms and neutral molecules, which then diffuse into the surface of the disc forming a carbon diffusion layer. When the plasma treatment is carried out at a relatively low temperature ranging from 300 to 550° C., the carbon atoms mainly reside in the cobalt lattices, forming a supersaturated solid solution with a possible nanocrystalline structure due to the relatively low temperatures employed in the treatment. The resultant layer has a high hardness, good fatigue strength and excellent wear and corrosion resistance (see below). When the plasma treatment is carried out at a relatively high temperature ranging from 600 to 700° C., the carbon atoms partially reside in the cobalt lattices forming a supersaturated solid solution and partially combined with carbon forming chromium carbides. The resultant layer has a high hardness, fatigue strength and excellent wear resistance.
  • After the completion of the plasma treatment, the glow discharge was turned off and the articles 22 were allowed to cool in the vessel 10 in the treatment atmosphere down to room temperature before they were removed from the vessel.
  • The articles 22 were then subjected to X-ray diffraction analysis for phase identification, glow discharge spectrometry (GDS) analysis for chemical composition determination, surface hardness measurements, metallography analysis of the cross section, electrochemical corrosion tests and wear tests.
  • A typical micrograph showing the cross-section of the carburised sample is given in FIG. 2. The sample was electrolytically etched in a 10% H2SO4 water solution. It can be seen that the carburised specimen is characterised by an “un-etched layer” on the surface followed by a carbon diffusion layer (“case”) beneath and the heavily etched substrate (“core”). The un-etched layer is dense, no details can be revealed even under high resolution FEG-SEM. The thickness of the total carburised case depth increases with increasing carburising temperature. In conjunction with the chemical composition analysis, the case depth was determined to be 3.1, 9.3 and 20.2 μm respectively for the A-sample treated at 400° C., 500° C. and 600° C. for 10 hours.
  • FIG. 3 shows the XRD patterns for the untreated and carburised Co-27.6Cr-5.5Mo-0.06C alloy (Sample A). As can be seen, the untreated alloy consists of a mixture of f.c.c. structured γ-Co and h.c.p. structured ε-Co. It can be deduced from the height of the XRD peaks that the untreated alloy contains mainly γ with a small amount of ε. Plasma carburising has changed the phase constituent in the alloy surface. As shown in FIG. 3, only two main diffraction peaks at lower angles and some minor peaks at higher angles are detected. These peaks could not be matched to either γ-Co, ε-Co or any other phases given in the existing Powder Diffraction Database. However, they exhibit the same characteristics as those generated by the S-phase in plasma nitrided or carburised stainless steel (Y. Sun X. Li and T. Bell Surface Engineering, 1999, Vol 15, No. 1, pp 49-54). It thus follows that S-phase was indeed produced in the plasma carburised Co—Cr—Mo alloy surface. The two main S-phase peaks, indicated as S(111) and S(200), correspond to the γ(111) and γ(200) of the substrate but are at lower angles. It is thought that the peak shift is caused by the solution of carbon which expands the f.c.c lattice structure of the substrate.
  • The surface mechanical properties of the plasma carburised samples were assessed using a Mitutoyo MVK-H tester under various loads, ranging from 0.025 kg to 1 kg. FIG. 4 shows micro hardness measured on the sample A surface with various load. It can be seen that the hardness on the untreated surface (A000) is fairly stable under a testing load of above 0.05 kg, with an average value of HV 486. After carburising, the surface hardness of the Co—Cr—Mo alloy was increased under all testing loads. Under indentation loads below 0.1 kg, surface hardness values of more than 1100 HV were obtained for the 500° C. and 600° C. treated samples (A500 and A600 respectively). The surface hardness values for the 400° C. treated sample (A400) were not as high as those for the 500° C. and 600° C. treated samples, but they are still much higher than those for the untreated alloy. As the testing load increased, all the measured hardness values decreased, showing a hardness gradient with testing load and this with the indentation depth. Such a diffusion type of hardness distribution is essential in ensuring optimum performance of surface treated system, since a sudden structural, compositional, and property change at the layer/core interface may lead to catastrophic interfacial failure of the layer during service. It was also found that the edges of the Vickers indentation impressions on the carburised samples were sharp and clear. No cracks were observed around or inside the indentation impression, and there was no evidence of interfacial failure between the carburised layer and the substrate even at a higher load of 1 kg. These observations suggest that the carburised layer possesses good ductility, high toughness and high load bearing capacity.
  • Plasma carburised and untreated test pieces were subjected to pin (WC ball)-on-disc wear tests sliding against 8 mm WC balls at a speed of 0.03 m/s with a initial maximum Hertzian contact stress of 1500 MP. Wear rate, in terms of volume loss per meter sliding distance per Newton load (mm3m−1N−1), was calculated and is shown in FIG. 5. As can be seen from FIG. 5, the wear rate of all the carburised test pieces was dramatically reduced by more than one order of magnitude as compared with the untreated test pieces.
  • Electrochemical potentiondynamic sweep corrosion tests were conducted at room temperature in a flat cell with Ringer's solution which contained 9 g/l sodium chloride, 0.42 g/l potassium chloride, 0.48 g/l calcium chloride and 0.2 g/l sodium bicarbonate in distilled water. The polarisation curves are shown in FIG. 6. As compared with the untreated test piece, the corrosion potentials of all plasma carburised test pieces were moved to more passive values, indicating improved corrosion resistance. The current densities of both the untreated and the A400 and A500 test pieces are practically the same. The A600 test piece showed a higher current density scan potential was over −0.2V.
  • The applicability of the present invention is demonstrated in Table 3. Treatment was carried out at 500° C. for 10 hrs in a gas mixture of methane and hydrogen. Microhardness was measured on the treated sample with a Vicker's indenter at a load of 0.1 kgf, indicated as HV0.1. As can be seen, all five types of Co—Cr based alloys in wrought, cast or PM/HIP form can be effectively surface hardened by applying the method of the present invention.
    TABLE 3
    Surface hardness of samples A to F.
    Sample Number Condition Surface Hardness HV0.1
    Wrought 1200
    B Wrought 1150
    C Cast MMT) 1200
    D Cast (DEP) 1000
    E Cast (DRILL) 1240
    F PM/HIP 960
  • In a modification of the above dc plasma method not shown), an advanced active screen plasma technology can be used to treat articles made of Co—Cr based alloys with improved surface quality. The articles to be plasma treated are placed inside a metal screen which is connected to the cathodic potential. The worktable and the articles to be treated are placed in a floating potential or subject to a relatively lower bias voltage (e.g. −100˜−200V). As an example, a casting material (material D in Table 3) has been plasma treated in a active screen plasma unit and the surface hardness increased from <400HV0.1 (untreated material) to ˜1050HV0.1 (active screen plasma treated).

Claims (34)

1. A method of modifying a surface characteristic of a cobalt-chromium based alloy article, comprising plasma treating the article at a temperature in the range of from 300 to 700° C. and at a pressure of from 100 to 1500 Pa for 1 to 50 hours in an atmosphere comprising at least one carbon-containing gas, whereby to introduce carbon into a surface region of said article.
2. The method of claim 1, wherein the surface characteristic to be modified is one or more of hardness, wear resistance, corrosion resistance and fatigue strength.
3. The method of claim 1, wherein the article whose surface characteristic is to be modified is a medical implant, such as a joint or knee prosthesis.
4. The method of claim 3, wherein the plasma treating is carried out at a temperature in the range of from 350 to 550° C.
5. The method of claim 4, wherein the plasma treating is carried out at a temperature in the range of from 400 to 500° C.
6. The method of claim 1, wherein the article whose surface characteristic is to be modified is an engineering component, such as a knife, valve, blade or shaft.
7. The method of claim 6, wherein the plasma treating is carried out at a temperature in the range of from 450 to 700° C.
8. The method of claim 7, wherein the plasma treating is carried out at a temperature in the range of from 600 to 650° C.
9. The method of claim 1, wherein said treatment pressure is in the range of from 400 to 600 Pa.
10. The method of claim 1, wherein the duration of said treatment is in the range of from 1 to 50 hours.
11. The method of claim 10, wherein the duration of said treatment is in the range of from 5 to 30 hours.
12. The method of claim 1, wherein the or each carbon-containing gas is selected from a hydrocarbon, carbon dioxide and carbon monoxide.
13. The method of claim 1, wherein the plasma treatment is carried out in the presence of at least one unreactive gas selected from hydrogen, helium, argon or other noble gas.
14. The method of claim 1, wherein the plasma treatment is carried out in the presence of at least one reactive gas.
15. The method of claim 14, wherein the reactive gas is a nitrogen containing gas.
16. The method of claim 15, wherein the plasma treatment is effected at a temperature in the range of from 300 to 500° C.
17. The method of claim 14, wherein said reactive gas constitutes from 0.5 to 10% by volume of the total atmosphere.
18. The method of claim 13, wherein the unreactive gas is hydrogen or a mixture of hydrogen and argon, and the carbon-containing gas is methane.
19. The method of claim 1, wherein the or each carbon-containing gas constitutes from 0.5 to 20% by volume of the total atmosphere.
20. The method of claim 1, wherein said plasma treatment is effected in the absence of oxygen.
21. The method of claim 1 which includes an article cleaning step prior to the plasma treatment to remove oxide scale.
22. The method of claim 21, wherein cleaning is effected by sputter cleaning.
23. The method of claim 21, wherein said cleaning step is effected at or below the subsequent plasma treatment temperature in an atmosphere of one or more of gases selected from hydrogen, helium, argon or other noble gas.
24. The method of claim 1, wherein the article is cooled after the plasma treatment.
25. The method of claim 24, wherein the rate of cooling is from 0.1° C./min up to 1000° C./min.
26. The method of claim 24, wherein the cooling is achieved by relatively slow cooling in the plasma treating atmosphere or by relatively fast cooling by quenching in a liquid.
27. The method of claim 1, wherein a passivation and/or polishing step is effected after completion of the plasma treatment.
28. A surface-hardened cobalt-chromium based article producible by the method of claim 1, said article characterised by having:
(i) a surface region comprising a supersaturated solid solution of carbon in cobalt or,
(ii) a surface region comprising a supersaturated solid solution of carbon in cobalt and chromium carbides.
29. The article of claim 28, wherein said surface region has a thickness in the range of from 3 to 50 μm.
30. The method of claim 1, wherein the Co—Cr based alloy includes one or more other alloying ingredients selected from molybdenum, nickel, tungsten, titanium and carbon.
31. The article of claim 30, wherein carbon is present in an amount of from 0.04 to 1.6 wt %.
32. The article of claim 31, wherein the article is a medical implant and carbon is present in the range of from 0.04 to 0.4 wt %.
33. The article of claim 31, wherein the article is an engineering component and carbon is present in the range of from 0.4 to 1.6 wt %.
34. The article of claim 28 which is a conventional hip or knee joint prostheses, a metal-on-metal advanced bone conservation prostheses, a dental implant or other implant device, a knife, blade for chemical or food processing industrials, a turbine blade, a valve or pump in the chemical and power industries, a bushing, steel mill equipment, a die, punch or mould.
US10/513,129 2002-04-29 2003-04-23 Surface treatment of co-cr based alloys using plasma carburization Abandoned US20050241736A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/946,569 US20130304219A1 (en) 2002-04-29 2013-07-19 Surface treatment of co-cr based alloys using plasma carburization

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0209797.0 2002-04-29
GBGB0209797.0A GB0209797D0 (en) 2002-04-29 2002-04-29 Method of surface hardening cobalt-chromium based alloy articles
PCT/GB2003/001702 WO2003093527A1 (en) 2002-04-29 2003-04-23 Surface treatment of co-cr based alloys using plasma carburization

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/001702 A-371-Of-International WO2003093527A1 (en) 2002-04-29 2003-04-23 Surface treatment of co-cr based alloys using plasma carburization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/946,569 Continuation US20130304219A1 (en) 2002-04-29 2013-07-19 Surface treatment of co-cr based alloys using plasma carburization

Publications (1)

Publication Number Publication Date
US20050241736A1 true US20050241736A1 (en) 2005-11-03

Family

ID=9935730

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/513,129 Abandoned US20050241736A1 (en) 2002-04-29 2003-04-23 Surface treatment of co-cr based alloys using plasma carburization
US13/946,569 Abandoned US20130304219A1 (en) 2002-04-29 2013-07-19 Surface treatment of co-cr based alloys using plasma carburization

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/946,569 Abandoned US20130304219A1 (en) 2002-04-29 2013-07-19 Surface treatment of co-cr based alloys using plasma carburization

Country Status (11)

Country Link
US (2) US20050241736A1 (en)
EP (1) EP1499755B1 (en)
JP (1) JP4403508B2 (en)
KR (1) KR101004948B1 (en)
AT (1) ATE396285T1 (en)
AU (1) AU2003226552B2 (en)
DE (1) DE60321156D1 (en)
DK (1) DK1499755T3 (en)
ES (1) ES2307964T3 (en)
GB (1) GB0209797D0 (en)
WO (1) WO2003093527A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084961A3 (en) * 2006-01-18 2008-01-31 Smith & Nephew Inc Applications of diffusion hardening techniques
US20080241570A1 (en) * 2007-03-26 2008-10-02 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase and such medical component
US20080241350A1 (en) * 2007-03-26 2008-10-02 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase
US20090204213A1 (en) * 2008-02-13 2009-08-13 Depuy Products, Inc. Metallic implants
US7632575B2 (en) * 2003-12-03 2009-12-15 IMDS, Inc. Laser based metal deposition (LBMD) of implant structures
US20090324442A1 (en) * 2007-03-26 2009-12-31 Howmedica Osteonics Corp. Method for fabricating a biocompatible material having a high carbide phase and such material
US7666522B2 (en) * 2003-12-03 2010-02-23 IMDS, Inc. Laser based metal deposition (LBMD) of implant structures
US20100078123A1 (en) * 2008-09-30 2010-04-01 I Mark Huang Medical device having bonding regions and method of making the same
US20120239157A1 (en) * 2007-08-20 2012-09-20 Depuy Products, Inc. Ultra-passivation of chromium containing alloy and methods of producing same
WO2014006390A2 (en) * 2012-07-05 2014-01-09 The University Of Birmingham Long-Lasting Antibacterial Metallic Surfaces and Methods for their Production
US9192694B2 (en) 2007-10-03 2015-11-24 Kyocera Medical Corporation Biocompatible and low-abrasion member, and artificial joint using the same and method of producing the same
US10626490B2 (en) * 2013-04-17 2020-04-21 Ald Vacuum Technologies Gmbh Process and apparatus for thermochemically hardening workpieces

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361194B2 (en) 2004-10-14 2008-04-22 Wright Medical Technology, Inc. Metallic bearings for joint replacement
JP2007277710A (en) * 2006-03-15 2007-10-25 Japan Medical Materials Corp Cobalt-chromium base alloy material and method for manufacturing the same
DE102007013638A1 (en) * 2007-03-19 2008-09-25 Degudent Gmbh Method of polishing metallic tooth reconstructions
JP2010144184A (en) * 2008-12-16 2010-07-01 Japan Medical Materials Corp Biomedical cast substrate of cobalt-chromium-based alloy superior in diffusion hardening treatability, biomedical sliding alloy member, and artificial joint
CN101496910B (en) * 2009-03-10 2017-06-23 成都西南交大研究院有限公司 A kind of degradable blood vessel support
US20130085575A1 (en) 2010-06-11 2013-04-04 Keita Ishimizu Cast base for biomedical use formed of cobalt-chromium based alloy and having excellent diffusion hardening treatability, sliding alloy member for biomedical use and artificial joint
CN103545163B (en) * 2012-07-10 2016-11-16 中芯国际集成电路制造(上海)有限公司 There is the processing method of the semiconductor structure of fluorine residue or chlorine residual
FR3042563B1 (en) * 2015-10-16 2017-10-27 Airbus Operations Sas INTERFACE OF FRICTION ADAPTATION BETWEEN TWO PIECES OF NICKEL OR ALLOY OF NICKEL OR COBALT CHROME IN RELATIVE MOTION AGAINST THE OTHER AT HIGH TEMPERATURE
CN108201473A (en) * 2016-12-19 2018-06-26 天津市杰冠医疗科技有限公司 Polishing method for dental laser fusion-cast dental parts
JP6990162B2 (en) * 2018-10-15 2022-01-12 株式会社神戸製鋼所 Nitriding processing equipment and nitriding processing method
KR102437508B1 (en) 2020-12-09 2022-08-30 한국생산기술연구원 Method For Treatmenting Surface Of CoCr Alloy Manufactured By 3D Printing Using Plasma Electrolytic Polishing
CN113102693B (en) * 2021-05-06 2022-11-29 四川固锐德科技有限公司 Preparation method of planetary wheel set for heavy-duty vehicle wheel edge system
CN115110088B (en) * 2022-08-26 2022-11-29 易生科技(北京)有限公司 Cobalt-chromium alloy member treatment liquid, preparation method and application thereof, and cleaning method of cobalt-chromium alloy member

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193825A (en) * 1977-06-28 1980-03-18 Kayaba Industry Co., Ltd. Method of carbon nitriding a metal workpiece
US5308412A (en) * 1993-03-15 1994-05-03 Zimmer, Inc. Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices
US5380547A (en) * 1991-12-06 1995-01-10 Higgins; Joel C. Method for manufacturing titanium-containing orthopedic implant devices
US5415704A (en) * 1992-02-07 1995-05-16 Smith & Nephew Richards Inc. Surface hardened biocompatible metallic medical implants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2747398B1 (en) * 1996-04-12 1998-05-15 Nitruvid METHOD FOR THE SURFACE TREATMENT OF A METAL PART

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193825A (en) * 1977-06-28 1980-03-18 Kayaba Industry Co., Ltd. Method of carbon nitriding a metal workpiece
US5380547A (en) * 1991-12-06 1995-01-10 Higgins; Joel C. Method for manufacturing titanium-containing orthopedic implant devices
US5415704A (en) * 1992-02-07 1995-05-16 Smith & Nephew Richards Inc. Surface hardened biocompatible metallic medical implants
US5498302A (en) * 1992-02-07 1996-03-12 Smith & Nephew Richards, Inc. Surface hardened biocompatible metallic medical implants
US5308412A (en) * 1993-03-15 1994-05-03 Zimmer, Inc. Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632575B2 (en) * 2003-12-03 2009-12-15 IMDS, Inc. Laser based metal deposition (LBMD) of implant structures
US7666522B2 (en) * 2003-12-03 2010-02-23 IMDS, Inc. Laser based metal deposition (LBMD) of implant structures
US10512544B2 (en) 2006-01-18 2019-12-24 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US9775713B2 (en) 2006-01-18 2017-10-03 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US11351031B2 (en) 2006-01-18 2022-06-07 Smith & Nephew, Inc. Applications of diffusion hardening techniques
AU2012238259B2 (en) * 2006-01-18 2015-03-05 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US20080281429A1 (en) * 2006-01-18 2008-11-13 Smith & Nephew, Inc. Applications of Diffusion Hardening Techniques
AU2015203048B2 (en) * 2006-01-18 2016-03-03 Smith & Nephew, Inc. Applications of diffusion hardening techniques
WO2007084961A3 (en) * 2006-01-18 2008-01-31 Smith & Nephew Inc Applications of diffusion hardening techniques
AU2007205890B2 (en) * 2006-01-18 2012-07-12 Smith & Nephew Inc. Applications of diffusion hardening techniques
US20090324442A1 (en) * 2007-03-26 2009-12-31 Howmedica Osteonics Corp. Method for fabricating a biocompatible material having a high carbide phase and such material
US8057914B2 (en) * 2007-03-26 2011-11-15 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase and such medical component
US9776246B2 (en) 2007-03-26 2017-10-03 Howmedica Osteonics Corp. Method for fabricating a biocompatible material having a high carbide phase and such material
US7771775B2 (en) 2007-03-26 2010-08-10 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase
US8920534B2 (en) 2007-03-26 2014-12-30 Howmedica Osteonics Corp. Method for fabricating a biocompatible material having a high carbide phase and such material
US20080241570A1 (en) * 2007-03-26 2008-10-02 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase and such medical component
US20080241350A1 (en) * 2007-03-26 2008-10-02 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase
US20120239157A1 (en) * 2007-08-20 2012-09-20 Depuy Products, Inc. Ultra-passivation of chromium containing alloy and methods of producing same
US9192694B2 (en) 2007-10-03 2015-11-24 Kyocera Medical Corporation Biocompatible and low-abrasion member, and artificial joint using the same and method of producing the same
US20090204213A1 (en) * 2008-02-13 2009-08-13 Depuy Products, Inc. Metallic implants
US8535806B2 (en) * 2008-09-30 2013-09-17 Cordis Corporation Medical device having bonding regions and method of making the same
US8133346B2 (en) 2008-09-30 2012-03-13 Cordis Corporation Medical device having bonding regions and method of making the same
US20110008626A1 (en) * 2008-09-30 2011-01-13 I Mark Huang Medical device having bonding regions and method of making the same
US20100078123A1 (en) * 2008-09-30 2010-04-01 I Mark Huang Medical device having bonding regions and method of making the same
WO2014006390A3 (en) * 2012-07-05 2014-07-17 The University Of Birmingham Long-lasting antibacterial metallic surfaces and methods for their production
WO2014006390A2 (en) * 2012-07-05 2014-01-09 The University Of Birmingham Long-Lasting Antibacterial Metallic Surfaces and Methods for their Production
CN104583446A (en) * 2012-07-05 2015-04-29 伯明翰大学 Long-lasting antibacterial metallic surfaces and methods for their production
US20150202842A1 (en) * 2012-07-05 2015-07-23 The University Of Birmingham Long-Lasting Antibacterial Metallic Surfaces and Methods for their Production
US10626490B2 (en) * 2013-04-17 2020-04-21 Ald Vacuum Technologies Gmbh Process and apparatus for thermochemically hardening workpieces

Also Published As

Publication number Publication date
GB0209797D0 (en) 2002-06-05
EP1499755A1 (en) 2005-01-26
DE60321156D1 (en) 2008-07-03
ES2307964T3 (en) 2008-12-01
DK1499755T3 (en) 2008-09-29
AU2003226552B2 (en) 2009-03-12
AU2003226552A1 (en) 2003-11-17
JP2005524772A (en) 2005-08-18
US20130304219A1 (en) 2013-11-14
JP4403508B2 (en) 2010-01-27
WO2003093527A1 (en) 2003-11-13
EP1499755B1 (en) 2008-05-21
KR101004948B1 (en) 2010-12-28
KR20050016375A (en) 2005-02-21
ATE396285T1 (en) 2008-06-15

Similar Documents

Publication Publication Date Title
US20130304219A1 (en) Surface treatment of co-cr based alloys using plasma carburization
Yildiz et al. Wear and corrosion behaviour of various surface treated medical grade titanium alloy in bio-simulated environment
Muthukumaran et al. Experimental investigation on corrosion and hardness of ion implanted AISI 316L stainless steel
Dearnley et al. The corrosion–wear behaviour of thermally oxidised CP-Ti and Ti–6Al–4V
Dong S-phase surface engineering of Fe-Cr, Co-Cr and Ni-Cr alloys
Lei et al. In vitro corrosion resistance of plasma source ion nitrided austenitic stainless steels
AU2007205890B2 (en) Applications of diffusion hardening techniques
Tekdir et al. Corrosion properties of ceramic-based TiO2 films on plasma oxidized Ti6Al4V/316L layered implant structured manufactured by selective laser melting
Ng et al. NiTi shape memory alloy with enhanced wear performance by laser selective area nitriding for orthopaedic applications
Jambagi et al. A review on surface engineering perspective of metallic implants for orthopaedic applications
Cui et al. Bio-tribocorrosion behavior of a nanocrystalline TiZrN coating on biomedical titanium alloy
Zhao et al. In vitro bio-tribological behaviour of textured nitride coating on selective laser melted Ti-6Al-4V alloy
Shukla et al. Low pressure plasma nitrided CoCrMo alloy utilising HIPIMS discharge for biomedical applications
Shen et al. Formation, tribological and corrosion properties of thicker Ti-N layer produced by plasma nitriding of titanium in a N2-NH3 mixture gas
Zhang et al. Enhancement of wear and corrosion resistance of low modulus β-type Zr-20Nb-xTi (x= 0, 3) dental alloys through thermal oxidation treatment
Buechel et al. Properties of materials used in orthopaedic implant systems
Sun et al. Tribocorrosion behavior of duplex S/Cr (N) and S/Cr (C) coatings on CoCrMo alloy in 0.89% NaCl solution
Guzman et al. Tribocorrosion behavior of niobium-based thin films for biomedical applications
Singh et al. Methods of improvement of mechanical and tribological properties of the surface of ss 316l: a review
JP2007277710A (en) Cobalt-chromium base alloy material and method for manufacturing the same
Becker et al. Production of porous sintered Co–Cr–Mo alloys for possible surgical implant applications: part 2: corrosion behaviour
Zhu et al. Tribocorrosion behavior of Nb coating deposited by double-glow plasma alloying
Xu et al. Improved wear and corrosion resistance of biomedical TiZrNbTaMo medium-entropy alloy by thermal oxidation treatment
González-Carrasco et al. Thermal oxidation treatments in the development of new coated biomaterials: Application to the MA 956 superalloy
Brühl et al. Wear behavior of plasma nitrided AISI 420 stainless steel

Legal Events

Date Code Title Description
AS Assignment

Owner name: AD.SURF.ENG LTD, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BELL, THOMAS;DONG, HANSHAN;LI, CHENXI;REEL/FRAME:016088/0640

Effective date: 20041210

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION